ArticleCancer immunology, immunotherapy : CII2023

Prevalence of mismatch repair genes mutations and clinical activity of PD-1 therapy in Chinese prostate cancer patients.

Bangwei Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.